Zeo ScientifiX, Inc.

ZEOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $2.3M $221.0K $657.0K $1.8M $3.8M $108.6K $590.8K $132.6K
Accounts Receivable $245.0K $35.0K $194.0K $18.0K $55.1K $104.2K $29.4K $26.0K
Inventory $796.0K $423.0K $232.0K $310.0K $248.5K $234.8K $146.8K $78.0K
Total Current Assets $3.5M $958.0K $1.2M $2.2M $4.4M $517.2K $845.8K $357.9K
Property, Plant & Equipment $595.0K $569.0K $478.0K $573.0K $1.7M $1.1M $365.2K $263.3K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $4.1M $1.5M $1.6M $2.8M $6.2M $1.9M $1.3M $649.1K
Liabilities
Accounts Payable $2.1M $2.0M $1.7M $2.6M $2.4M $1.9M $765.7K $552.4K
Total Current Liabilities $3.4M $2.9M $3.3M $4.0M $4.1M $4.1M $2.5M $2.1M
Long-Term Debt — — — — — — — $153.2K
Total Liabilities $3.5M $3.0M $3.3M $4.0M $4.3M $4.6M $2.7M $2.2M
Stockholders' Equity
Retained Earnings $-72.8M $-67.7M $-62.2M $-57.5M $-50.5M $-41.6M $-28.9M $-16.3M
Total Stockholders' Equity $583.0K $-1.4M $-1.7M $-1.2M $1.9M $-2.7M $-1.4M $-1.6M
← Newer Page 1 of 2 Older →